Metagenomi Therapeutics, Inc. (MGX) ROA
- 2026-06-30: ROA -53.81%.
- 2026-03-31: ROA -43.61%.
- 2025-12-31: ROA -39.74%.
- 2025-09-30: ROA -35.79%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -53.81% |
| 2026-03-31 | -43.61% |
| 2025-12-31 | -39.74% |
| 2025-09-30 | -35.79% |
| 2025-06-30 | -32.00% |
| 2025-03-31 | -26.17% |
| 2024-12-31 | -24.05% |
| 2024-09-30 | -20.64% |
| 2024-06-30 | -19.44% |
| 2024-03-31 | -18.60% |
| 2023-12-31 | -18.71% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -39.74% |
| 2024-12-31 | -24.05% |
| 2023-12-31 | -18.71% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |